All In Biotech

Free tool

FAERS Monitor: Reyataz

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206352 or its brand name (Reyataz, Atazanavir Sulfate). Reports on generic versions are filed under their own applications.

Reports

11,467

Serious

10,029

87% of reports

Hospitalization

3,551

Death reported

780

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug interaction931
  • anxiety759
  • pain740
  • foetal exposure during pregnancy718
  • emotional distress651
  • depression620
  • anhedonia592
  • renal failure453
  • nephrolithiasis441
  • nausea424
  • fatigue395
  • chronic kidney disease394
  • osteoporosis394
  • hyperbilirubinaemia346
  • jaundice340

Reports by year received

View as table
YearReports
2004345
2005459
2006496
2007362
2008395
2009598
2010689
2011769
2012892
2013623
2014720
2015808
2016715
2017553
2018545
2019608
2020605
2021499
2022387
2023207
202488
202566
202636

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,692 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperbilirubinaemiaSignal34663.457.020,475
anhedoniaSignal59242.239.023,292
jaundiceSignal34023.521.17,208
nephrolithiasisSignal44117.816.26,923
osteoporosisSignal39417.716.16,156
foetal exposure during pregnancySignal71816.315.210,271
drug interactionSignal93110.810.28,303
emotional distressSignal6519.99.25,209
chronic kidney diseaseSignal3949.68.73,005
renal failureSignal4536.35.72,009
depressionSignal6205.04.62,002
anxietySignal7594.94.62,380
painSignal7402.22.1504
nausea4241.00.90
fatigue3950.90.82

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.